Scarica l'app Stockscreener
4.66
2.64%
0.12
Dopo l'orario di chiusura:
4.67
0.010
+0.21%
Precedente Chiudi:
$4.54
Aprire:
$4.635
Volume 24 ore:
147.14K
Relative Volume:
0.19
Capitalizzazione di mercato:
$318.84M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-2.1674
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+2.19%
1M Prestazione:
+11.22%
6M Prestazione:
-20.34%
1 anno Prestazione:
-69.32%
Intervallo 1D:
$4.63
$4.75
Intervallo di 1 settimana:
$4.37
$4.75
Portata 52W:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.66 | 310.63M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Is Olema Pharmaceuticals Inc. a good long term investmentConsistent high-performance stocks - Autocar Professional
Olema Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
What analysts say about Olema Pharmaceuticals Inc. stockRemarkable growth - jammulinksnews.com
What drives Olema Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
What makes Olema Pharmaceuticals Inc. stock price move sharplyDaily Top Gainers - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Olema Pharmaceuticals Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Oncology Awards $675K Worth of Stock Options to Key New Hires in Breast Cancer Research - Stock Titan
Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX
Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat
Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World
ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):